Russell W. Chan

Russell W. Chan received the B.Eng. degree in biomedical engineering and the Ph.D. degree in electrical and electronic engineering from The University of Hong Kong, Hong Kong, in 2011 and 2016, respectively. He held a postdoctoral position in neurology and neurological sciences at Stanford University, Stanford, CA, USA, from 2017 to 2020, and the Neuroscience Institute, Tech4Health Institute and Ophthalmology, New York University, New York, NY, USA, from 2020 to 2021. He is a Co-Founder of Gense Technologies Ltd. He has published 14 journal articles and 63 conference papers, including Proceedings of the National Academy of Sciences (PNAS) and Neuron. His research focus is the development and application of state-of-the-art multimodal and multiscale biomedical imaging and bioengineering to advance biotechnology and quality of life. These methodologies include functional MRI, optoacoustic tomography (OAT), electrical impedance tomography (EIT), and optogenetic neuromodulation. Dr. Chan is an elected Junior Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM), a highly selected and prestigious award by the leading MRI community.